致力于发现与开发治疗癌症及其他疾病的新型、差异化疗法。港交所代码：02256HKEx code：02256

和誉医药

Director, Translational and Biomarker Research

Scientist II - III

Scientist

VP Biometrics

Director Biostatistics

Statistical Consultant

Principal statistician

Senior statistician

Senior Biostatistician

Head of CMC, VP

Director, CMC Leader/China SM Analytical Development Head

BMS WuXi Analytical & Stability Center (BWASC) Onsite Head

Senior Director, Analytical Development

Research Fellow / Director

Manager, Global Quality Analytical Development

Research Chemist

Postdoctoral Associate

Business Development Assistant

Research Lab Assistant

General Vice President

Director of Service Department

Member of Service Department

Associate Director, Business Development

Senior Manager, Business Development

Associate Manager, Business Development

Assistant to COO

Specialist

Chief Medical Officer

VP, Head of CVRM TA; Head of ClinPharm and Drug Safety

Director, Exploratory Medicine, Discovery Center

Head of clinical development and medical affairs

Head of CRU

BD Head

Director of External Innovation & Partnerships

AD External Innovation

Investigator III

Investigator II

Scientist II/ Investigator I

Assistant researcher

Compensation and Benefit

高级咨询经理

Human Resource Head，China

HR C&B Mgr.，China

Chief Scientific Officer

Senior Vice President

Associate Director

Investigator II and III

Senior Scientist

Postdoc Researcher

Ph.D. student and postdoc research

Associate Director of Regulatory Affairs

Director of  Regulatory Affairs and Project Management

Senior Manager of Global Regulatory Affairs

Associate Manager of Global Regulatory Affairs

Supervisor of Global Regulatory Affairs

Microsoft Office 365

Google Tag Manager

Mobile Friendly

Microsoft-IIS

ASP.NET

Baidu Ads

Gloria Biosciences (誉衡生物) is a commercial stage biopharma company founded in 2016, bringing together a seasoned development and management team with global versions, and dedications to developing patient-centered treatments.In 2021, Gloria Bio has successfully launched and commercialized a novel, fully human anti-PD-1 mAb, zimberelimab ("Yutuo", "誉拓"), for the treatment of relapsed or refractory classical Hodgkin's lymphoma, which demonstrated an overall response rate (ORR) of 92.86%, DCR of 96.43%, and 12 month overall survival rate of 99% with improved long-term survival benefits for patients. Zimberelimab is also designated as Breakthrough Therapy by China's Center for Drug Evaluation for the treatment of recurrent or metastatic cervical cancer, which has been approved in July 2023, marking the first and only PD-1 mAb approved in China for cervical cancer, and third globally.Currently, zimberelimab is being evaluated in multiple types of cancer, including prostate, colorectal, non-small cell lung, pancreatic, triple-negative breast, head and neck, and renal cell cancers, etc. It is also being studied in combinations with multiple innovative drugs, targeting CD47, CD73, TIGIT, A2aR, CCR8, LAG-3, CD40, CD39, Trop-2, CAR-T, HER-2 ACD and Neo-T, etc.Gloria Biosciences is striving to build a pipeline with more effective treatment alternative for cancer patients, including LAG-3 and other innovative monoclonal and biospecific antibodies.

Gloria Biosciences

Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable, and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases, and ophthalmic diseases. Up to date, 5 products have been launched in China, 2 has been approved for marketing in overseas markets, 19 indications are approved worldwide, and 3 marketing applications have been accepted for review in China, the U.S. and EU, respectively. Since its inception in 2010, Henlius has built an integrated biopharmaceutical platform with core capabilities of high-efficiency and innovation embedded throughout the whole product life cycle including R&D, manufacturing and commercialization. It has established global innovation center and Shanghai-based manufacturing facilities in line with global Good Manufacturing Practice (GMP), including Xuhui Plant certificated by China and the EU GMP and Songjiang First Plant certificated by China GMP.Henlius has pro-actively built a diversified and high-quality product pipeline covering over 20 innovative monoclonal antibodies (mAbs) and has continued to explore immuno-oncology combination therapies with proprietary HANSIZHUANG (anti-PD-1 mAb) as backbone. Apart from the launched products HANLIKANG (rituximab), the first China-developed biosimilar, HANQUYOU (trastuzumab for injection, trade name in Europe: Zercepac®; trade names in Australia: Tuzucip® and Trastucip®, the first China-developed mAb biosimilar approved both in China and Europe, HANDAYUAN (adalimumab) and HANBEITAI (bevacizumab), HANSIZHUANG has been approved by the NMPA for the treatment of MSI-H solid tumors, sqNSCLC, ES-SCLC, and ESCC, making it the world's first anti-PD-1 mAb for the first-line treatment of SCLC. Its NDA for the treatment of nsNSCLC is under review. What's more, Henlius has conduct over 30 clinical studies for 16 products globally, expanding its presence in major markets as well as emerging markets.

Henlius

Bootstrap Framework

Viewpoint

At Revvity, "impossible" is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what's possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com

Senior Sales Representative - Remote (California)

Bottling Technician I - (2nd Shift 3PM-11:30PM)

Data Entry Clerk (1st Shift: 7AM - 3:30PM)

IT Project Manager Intern

Revvity

Akamai

Salesforce

NSOne

MailJet

Outlook

Team Leader, Vehicle Data System & Product

Staff Engineer, Data Science

Senior Engineer, Data Science

Data Scientist

Researcher

Graduate Student Researcher

New York Cancer & Blood Specialists

Medical Oncologist

Hematology Oncology Fellow

Medical Doctor

Hermès

Senior Communication Executive

Digital Content Supervisor

Creative Editor&Producer

Freelancer（Translator&Editor）

Fashion&Beauty Editor（intern）

JAS Worldwide

Accounts Receivable Specialist

Project Specialist, Bid Management

Administration Strategic Customer Development

National Sales Administration

McGill University - Faculty of Science

Associate Professor

Assistant Professor

FXVFP member

NUS Investment Society

Vice President Operations

Winning Women Program

Transaction Banking Intern

Human Resources Director

Investment Analyst

Human Resources and Operation Intern

Project Intern

Administrative Assistant

Trip.com Group

Product Director

Product Manager

Senior Project Manager

Program Specialist

Siemens Healthineers

Sr. Analyst of Accounting and Finance

Sr. Analyst of Finance and Accounting

Auditor

Financial Analyst

Senior Project Accountant

Financial Analyst/Consultant

Senior Accountant - Financial Reporting

Assistant Treasury Analyst

Accounting Representative

Accountant/Bookkeeper

Procurement Officer

Town Sports International

Front Desk

The North Face

Seasonal Sales Associate

Receptionist

Cashier

Medical Receptionist

Valley Bank

Quantitative Model Analyst

Graduate Research Assistant

Quantitative Analyst

Investment Banking Analyst

Quantitative Research Intern

Investment Banking Analyst Intern

Asset Management Analyst

Engineer

AVIC

工程师

Jin Guo

Associate Director, Business Development at 和誉医药

Jin Guo's Professional Contact Details

Jin Guo's Current Company Details

和誉医药

Jin Guo's Work History and Education

Others Named Jin Guo

Frequently Asked Questions about Jin Guo

What company does Jin Guo work for?

What is Jin Guo's role at 和誉医药?

What is Jin Guo's email address?

What is Jin Guo's business email address?

What is Jin Guo's HQ phone number?

What industry does Jin Guo work in?

Who are Jin Guo's colleagues?

Colleagues at 和誉医药

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?